Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics

From: Prevalence of foot problems in people with inflammatory arthritis in Singapore

Age, years 52.0 (14.5)
Women, n (%) 51 (50 %)
Ethnicity, n (%)
 Chinese 70 (69 %)
 Malay 11 (11 %)
 Indian 15 (15 %)
 Caucasian 0 (0 %)
 Other 5 (5 %)
 Body Mass Index, Kg/m2 27.2 (5.4)
 Smokers, n (%) 14 (14 %)
 Disease duration, years 9.3 (0.3)
Disease type, n (%)
 • Rheumatoid arthritis 46 (46 %)
 • Gout 31 (31 %)
 • Spondyloarthritis 15 (15 %)
 • Psoriatic arthritis 4 (4 %)
 • Undifferentiated inflammatory arthritis 5 (5 %)
Medications, n (%)
 • Methotrexate 42 (60 %)
 • Combination DMARD therapy (≥2 DMARDs) 52 (74 %)
 • Biologics 4 (6 %)
 • Prednisone 40 (40 %)
Other medications, n (%)
 NSAID, n (%) 49 (49 %)
 Diabetes Mellitus, n (%) 12 (12 %)
 Patient global VAS (VAS 0–100), mm 26 (26)
 Tender (28) joint count 1.8 (2.8)
 Swollen (28) joint count 1.3 (2.1)
 DAS28-ESR score 3.54 (1.1)
 ESR, mm/h 31.6 (21.2)
 CRP, mg/L 27.4 (32.2)
 mHAQ score 0.25 (0.36)
  1. Data presented as mean (SD) unless specified
  2. DMARD Disease modifying anti-rheumatic drug, NSAID Non steroidal anti-inflamamtory drugs, VAS Visual analogue scale, ESR Erythrocyte sedimentation rate, CRP C-reactive protein, DAS-28 disease activity score in 28 joints